SORCS3-AS1: A Potential Drug Target and Biomarker (G100505890)

Target Name: SORCS3-AS1

NCBI ID: G100505890

SORCS3-AS1

Other Name(s): SORCS3 antisense RNA 1

SORCS3-AS1: A Potential Drug Target and Biomarker

Sorcs3-AS1, also known as CSN4-AS1, is a protein that is expressed in the brain and is known to play a role in the regulation of synaptic plasticity, which is the ability of the brain to change and adapt over time. The study of Sorcs3-AS1 and its potential drug targets or biomarkers has gained significant attention in recent years, and there is a growing interest in using this protein as a therapeutic approach for various neurological and psychiatric disorders.

The Sorcs3-AS1 protein

Sorcs3-AS1 is a member of the superfamily of scaffold proteins, which are known to play a critical role in the structure and function of various proteins. Sorcs3-AS1 is characterized by a unique open-loop structure, which consists of a central尾-sheet and a distinct 尾-hinge. This unique structure allows Sorcs3-AS1 to form a complex with other proteins, including neurotransmitter receptors, and to participate in various signaling pathways that are involved in brain function.

In addition to its unique structure, Sorcs3-AS1 is also known for its ability to interact with other proteins. Studies have shown that Sorcs3-AS1 can form a complex with the neurotransmitter receptor, 尾2-adrenergic receptor, and the protein, synaptochrome, which is involved in synaptic plasticity. These interactions between Sorcs3-AS1 and other proteins suggest that it plays a critical role in the regulation of synaptic plasticity and may be a potential drug target or biomarker.

The potential drug targets of Sorcs3-AS1

Sorcs3-AS1 has been identified as a potential drug target for various neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and depression. The reason for this is the role that Sorcs3-AS1 plays in the regulation of synaptic plasticity, which is believed to be disrupted in these disorders. By targeting Sorcs3-AS1, researchers may be able to improve synaptic plasticity and potentially slow the progression of these disorders.

One of the potential drug targets of Sorcs3-AS1 is the neurotransmitter receptor, 尾2-adrenergic receptor. The 尾2-adrenergic receptor is involved in the regulation of cardiovascular and respiratory function, and is also involved in the regulation of synaptic plasticity. Studies have shown that Sorcs3-AS1 can interact with the 尾2-adrenergic receptor and that this interaction may play a role in the regulation of synaptic plasticity. Therefore, targeting Sorcs3-AS1 with a 尾2-adrenergic receptor antagonist may be a potential approach for the treatment of Alzheimer's disease and other disorders.

Another potential drug target of Sorcs3-AS1 is the protein, synaptochrome. Synaptochrome is a protein that is involved in the regulation of synaptic plasticity and is expressed in the brain. Studies have shown that Sorcs3-AS1 can interact with synaptochrome and that this interaction may play a role in the regulation of synaptic plasticity. Therefore, targeting Sorcs3-AS1 with a drug that blocks synaptochrome activity may be a potential approach for the treatment of depression and other disorders.

The potential biomarkers of Sorcs3-AS1

Sorcs3-AS1 has also been identified as a potential biomarker for various neurological and psychiatric disorders. The reason for this is the role that Sorcs3-AS1 plays in the regulation of synaptic plasticity, which is believed to be disrupted in these disorders. By measuring the level of Sorcs3-AS1 in brain tissue or fluids, researchers may be able to identify potential biomarkers for these disorders.

One of the potential biomarkers of Sorcs3-AS1 is the level of Sorcs3-AS1 in the brain. Studies have shown that the level of Sorcs3-AS1 in the brain is decreased in individuals with Alzheimer's disease and other disorders. Therefore, measuring the level of Sorcs3-AS1 in brain tissue or fluids may be a potential approach

Protein Name: SORCS3 Antisense RNA 1

The "SORCS3-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SORCS3-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets